ACTA GASTRO-ENTEROLOGICA BELGICA, cilt.82, sa.2, ss.273-277, 2019 (SCI-Expanded)
Background and study aims : The aim of this study was to enlighten the controversy about the renal safety of entecavir, tenofovir, and telbivudine treatments in chronic hepatitis B (CHB) patients by comparing these treatments in real-world conditions.